<p>WANJIA GROUP (00401.HK) announced a proposed rights issue to issue at least 560 million shares; the rights issue price is HKD 0.08, representing a discount of 31.62% compared to the last trading day (30th). The net fundraising amount is not less than HKD 40.82 million, intended for the development of existing pharmaceutical wholesale and distribution business, as well as blood dialysis treatment and consulting services business and potential investment opportunities; repayment of amounts owed to a director; and general working capital</p>

00401

<p>WANJIA GROUP announced a proposed one-for-one rights issue, issuing at least 560 million shares; the rights issue price is HKD 0.08, representing a discount of 31.62% compared to the last trading day (30th). The net proceeds are not less than HKD 40.82 million, intended for the development of existing pharmaceutical wholesale and distribution business, as well as blood dialysis treatment and consulting services business and potential investment opportunities; repayment of amounts owed to a director; and general working capital</p>

WANJIA GROUP offers a rights issue at a discount of 31.62%, raising at least HKD 40.82 million